{"id":"clm_75285D1846DF","entity":"astrazeneca","predicate":"revenue","value":"58,739,000,000 United States dollar","value_json":{"fy":2025,"accn":"0001104659-26-019130","form":"20-F","filed":"2026-02-24","concept":"ifrs-full:Revenue"},"valid_from":"2025-12-31","valid_to":null,"published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"AstraZeneca revenue: 58,739,000,000 United States dollar\", as of 2025-12-31. Claim clm_75285D1846DF, https://asof.is/claim/clm_75285D1846DF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm.","url":"https://asof.is/claim/clm_75285D1846DF","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"supersedes":["clm_5BDDB85A5719"],"first_seen_at":"2026-11-08T15:36:55.56137+00:00","updated_at":"2026-11-08T15:36:55.56137+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Revenue in 20-F FY2025, filed 2026-02-24"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}